CRBU
Price
$1.57
Change
-$0.06 (-3.68%)
Updated
Jul 24 closing price
Capitalization
155.71M
18 days until earnings call
Intraday BUY SELL Signals
PROK
Price
$1.50
Change
-$0.02 (-1.32%)
Updated
Jul 24 closing price
Capitalization
307.8M
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBU vs PROK

CRBU vs PROK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRBU vs. PROK commentary
Jul 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a StrongBuy and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2026
Stock price -- (CRBU: $1.57 vs. PROK: $1.50)
Brand notoriety: CRBU and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 32% vs. PROK: 98%
Market capitalization -- CRBU: $155.71M vs. PROK: $307.8M
CRBU [@Biotechnology] is valued at $155.71M. PROK’s [@Biotechnology] market capitalization is $307.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBU is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 3 TA indicator(s) are bullish while PROK’s TA Score has 3 bullish TA indicator(s).

  • CRBU’s TA Score: 3 bullish, 7 bearish.
  • PROK’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, PROK is a better buy in the short-term than CRBU.

Price Growth

CRBU (@Biotechnology) experienced а -4.85% price change this week, while PROK (@Biotechnology) price change was -7.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.78%. For the same industry, the average monthly price growth was -3.76%, and the average quarterly price growth was +1901.89%.

Reported Earning Dates

CRBU is expected to report earnings on Aug 12, 2026.

PROK is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-4.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($308M) has a higher market cap than CRBU($156M). CRBU YTD gains are higher at: -1.258 vs. PROK (-33.036). CRBU has higher annual earnings (EBITDA): -116.43M vs. PROK (-149.81M). PROK has more cash in the bank: 225M vs. CRBU (118M). PROK has less debt than CRBU: PROK (3.78M) vs CRBU (26.9M). CRBU has higher revenues than PROK: CRBU (11.2M) vs PROK (889K).
CRBUPROKCRBU / PROK
Capitalization156M308M51%
EBITDA-116.43M-149.81M78%
Gain YTD-1.258-33.0364%
P/E RatioN/AN/A-
Revenue11.2M889K1,260%
Total Cash118M225M52%
Total Debt26.9M3.78M711%
TECHNICAL ANALYSIS
Technical Analysis
CRBUPROK
RSI
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
72%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 9 days ago
74%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signal:
Gain/Loss:
PROK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BREFX40.770.77
+1.93%
Baron Real Estate Retail
AVLVX19.690.07
+0.36%
Avantis U.S. Large Cap Value Inst
PASSX63.92N/A
N/A
T. Rowe Price Small-Cap Stock Adv
TSFIX17.10N/A
N/A
Touchstone Small Cap Institutional
WCMWX25.51N/A
N/A
WCM Focused Emerging Mkts Ex Chn Inst

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RXRX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-1.32%
RXRX - PROK
52%
Loosely correlated
-1.66%
SANA - PROK
49%
Loosely correlated
-0.93%
ABCL - PROK
45%
Loosely correlated
-6.35%
BEAM - PROK
43%
Loosely correlated
-3.13%
CRBU - PROK
43%
Loosely correlated
-3.68%
More